We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fresh Microglia Destroy Alzheimer's Plaques

By Biotechdaily staff writers
Posted on 12 Mar 2006
Researchers have found that microglia, the specialized immune cells of the nervous system, were effective in destroying the amyloid plaques of Alzheimer's disease if they were recently derived from bone marrow stem cells, but not if they were long-term residents of the brain.

Investigators at the faculty of medicine of Université Laval (Quebec, CA) worked with a transgenic mouse model of human Alzheimer's disease. More...
They showed that in contrast to resident microglia, similar cells transferred from the bone marrow to the brain became highly branched and elongated within the core of amyloid plaques. Further results published in the February 16, 2006, issue of Neuron revealed that the microglia's phagocytic action dissolved the plaques.
"Stem cells should be harvested from the patients themselves, thus limiting the risks of both rejection and adverse effects,” said senior author Dr. Serge Rivest, professor of molecular endocrinology at Université Laval. "While this cellular therapy will not prevent Alzheimer's, by curbing plaque development, we believe that it will help patients prolong their autonomy and cognitive capacity. We believe that this is a new and powerful weapon in the fight to conquer Alzheimer's.”


Related Links:
Université Laval

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.